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Cell type–dependent mechanisms for 
formin-mediated assembly of filopodia
ABSTRACT Filopodia are finger-like protrusions from the plasma membrane and are of fun-
damental importance to cellular physiology, but the mechanisms governing their assembly 
are still in question. One model, called convergent elongation, proposes that filopodia arise 
from Arp2/3 complex–nucleated dendritic actin networks, with factors such as formins elon-
gating these filaments into filopodia. We test this model using constitutively active constructs 
of two formins, FMNL3 and mDia2. Surprisingly, filopodial assembly requirements differ be-
tween suspension and adherent cells. In suspension cells, Arp2/3 complex is required for filo-
podial assembly through either formin. In contrast, a subset of filopodia remains after Arp2/3 
complex inhibition in adherent cells. In adherent cells only, mDia1 and VASP also contribute 
to filopodial assembly, and filopodia are disproportionately associated with focal adhesions. 
We propose an extension of the existing models for filopodial assembly in which any cluster 
of actin filament barbed ends in proximity to the plasma membrane, either Arp2/3 complex 
dependent or independent, can initiate filopodial assembly by specific formins.
INTRODUCTION
Two abundant actin-based structures in metazoan cells are lamelli-
podia and filopodia (Blanchoin et al., 2014; Skau and Waterman, 
2015). Both structures consist of multiple actin filaments oriented 
with their fast-growing “barbed” ends toward the plasma mem-
brane but are morphologically distinct. Lamellipodia are sheet-like 
protrusions containing short, dendritically branched actin filaments. 
In contrast, filopodia are finger-like protrusions (<200 nm diameter) 
containing longer, unbranched filaments. In both structures, it is the 
addition of actin monomers to barbed ends that leads to membrane 
protrusion.
In keeping with their differing morphologies, the assembly 
mechanisms for lamellipodia and filopodia also differ. Lamellipodial 
assembly is well characterized, with actin-related protein 2/3 
(Arp2/3) complex being responsible for nucleating and cross-link-
ing the dendritic network and barbed end–capping proteins termi-
nating filament elongation (Blanchoin et al., 2014). In contrast, the 
details of filopodial assembly remain unclear, with two predomi-
nant models: convergent elongation and tip nucleation (Faix et al., 
2009; Yang et al., 2009). The convergent elongation model pro-
poses that filopodia arise directly from the lamellipodial dendritic 
network, dependent on Arp2/3 complex activity. A subset of these 
filaments is then reorganized by formins and/or Enabled/vasodila-
tor-stimulated phosphoprotein (ENA/VASP) proteins through their 
abilities to block capping proteins and allow sustained elongation 
(Svitkina et al., 2003; Yang et al., 2007). Actin-bundling proteins, 
including fascin and possibly formins and/or ENA/VASP proteins 
(Harris and Higgs, 2006; Harris et al., 2010; Schirenbeck et al., 
2006; Vignjevic et al., 2006; Block et al., 2008), further remodel 
elongating filaments into parallel bundles characteristic of 
filopodia.
The convergent elongation model has been supported by both 
in vitro studies (Vignjevic et al., 2003; Haviv et al., 2006) and cellular 
studies (Svitkina et al., 2003). However, there is also evidence for 
Arp2/3 complex–independent mechanisms of filopodial assembly 
(Steffen et al., 2006; Suraneni et al., 2012; Wu et al., 2012), prompt-
ing the tip nucleation model (Schirenbeck et al., 2006; Block et al., 
2008; Faix et al., 2009; Yang and Svitkina, 2011). In this model, for-
min proteins serve as both actin nucleation and elongation factors 
to assemble filopodial actin filaments.
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phoma cells, whereas an inactive analogue, CK689, has no effect 
(Figure 1E-G). We also confirmed these results using scanning elec-
tron microscopy (SEM; Supplemental Figure S2). Taken together, 
these data show that Arp2/3 complex is required for FMNL3 and 
mDia2-mediated filopodia in suspension cells, suggesting use of 
the convergent elongation model for their assembly.
A subset of filopodia persists upon Arp2/3 complex 
inhibition in adherent cells
We also tested the effect of CK666 on filopodial assembly in adher-
ent cells, initially using U2OS human osteosarcoma cells. As in sus-
pension cells, transfection with either GFP-FMNL3-FF or GFP-
mDia2-FFC induces filopodia with GFP enriched at their tips (Harris 
et al., 2010; Figure 2A). These structures are truly protrusive filopo-
dia and not retraction fibers, as judged by live-cell analysis (Supple-
mental Figure S3C and Supplemental Movie S1). Although there is 
significant variability in the dynamics of these filopodia both within 
a single cell and between cells, the average filopodial lifetime is 264 
± 153 s (Supplemental Figure S3B), with an average maximal length 
of 1.9 ± 0.8 mm (Supplemental Figure S3E).
In contrast to the results in suspension cells, CK666 only slightly 
reduces the percentage of cells possessing at least one filopodium 
(10% reduction for FMNL3 and 3% for mDia2; Figure 2B). However, 
the number of filopodia per cell is significantly reduced by CK666 
treatment, with 76% reduction for FMNL3 and 58% reduction for 
mDia2 (Figure 2C). We also tested CK666 effects in a second adher-
ent cell line, NIH 3T3 mouse fibroblasts. As in U2OS cells, CK666 
does not cause a large reduction in the percentage of FMNL3-FF–
transfected 3T3 cells displaying filopodia (8%), yet the number of 
filopodia per cell is significantly reduced (64%; Figure 2, D–F).
One possibility is that the filopodia remaining after CK666 treat-
ment represent a stable subtype that does not turn over during the 
treatment period. To test this possibility, we examined the effect of 
CK666 on live cells, comparing dynamics before and after treat-
ment. CK666 treatment decreases filopodial assembly rate by 75% 
(Supplemental Figure S3, D and F, and Supplemental Movie S2). 
The filopodia that do assemble in CK666-treated cells have shorter 
lifetimes than in the control condition (199 ± 105 s; Supplemental 
Figure S3B), whereas their average maximal length is similar (1.9 ± 
0.7 mm; Supplemental Figure S3E). These results suggest that the 
filopodia that remain after Arp2/3 complex inhibition do not repre-
sent a stable population.
One possible explanation for the difference between suspension 
cells and adherent cells is that CK666 is only partially effective on 
adherent cells. To test this possibility, we used small interfering RNA 
(siRNA) to suppress the Arp2 subunit in U2OS cells (∼80% depletion; 
Supplemental Figure 4A), followed by CK666 treatment. Our ratio-
nale was that the combination siRNA/CK666 treatment should 
cause a larger reduction in filopodial number if CK666 alone only 
partially inhibits Arp2/3 complex. However, combined siRNA/
CK666 treatment does not cause a further reduction in filopodia 
number (Figure 3A) or the percentage of cells displaying filopodia 
(Figure 3B) over CK666 alone, suggesting that CK666 inhibits the 
majority of active Arp2/3 complex. The situation is similar for both 
FMNL3 and mDia2. Micrographs representative of some of these 
conditions are shown in Supplemental Figure S4B.
Roles for mDia1 and VASP in filopodial assembly 
in adherent cells
Our inability to abolish filopodia by Arp2/3 complex inhibition in 
adherent cells prompted us to ask whether other nucleation factors 
may play a role. We previously found that constitutively active 
Biochemically, formin proteins have the ability to accelerate both 
actin nucleation and elongation, as well as to compete with capping 
proteins (Chesarone et al., 2010). Thus they are attractive candi-
dates for filopodia assembly by either convergent elongation or tip 
nucleation. Indeed, a number of cellular studies suggest that formins 
participate in filopodial assembly, notably mammalian Diaphanous 
(mDia)1 (Sarmiento et al., 2008; Goh et al., 2011; Naj et al., 2013), 
mDia2 (Pellegrin and Mellor, 2005; Yang et al., 2007; Block et al., 
2008; Harris et al., 2010), disheveled-associated activator of mor-
phogenesis-1 (DAAM1; Matusek et al., 2008; Jaiswal et al., 2013), 
formin-like 2 (FMNL2; Block et al., 2012), and FMNL3 (Harris et al., 
2010; Gauvin et al., 2015). Of interest, most of these formins (mDia2, 
DAAM1, FMNL2, and FMNL3) also have the ability to bundle actin 
filaments (Harris et al., 2006; Vaillant et al., 2008; Heimsath and 
Higgs, 2012; Jaiswal et al., 2013). However, it is unclear whether 
these formins serve as the nucleator in a tip nucleation–type model 
or use filaments nucleated by Arp2/3 complex.
Ena/VASP proteins have somewhat similar effects on actin as 
formins: elongation regulation, competitive inhibition of barbed 
end capping, and filament bundling (Bachmann et al., 1999; Bear 
et al., 2002; Barzik et al., 2005; Winkelman et al., 2014). Ena/VASP 
proteins have also been linked to filopodia assembly (Svitkina et al., 
2003; Lebrand et al., 2004; Applewhite et al., 2007) but are not al-
ways present in filopodial tips (Yang et al., 2007; Barzik et al., 2014) 
and are also enriched at other sites, such as focal adhesions, stress 
fibers, and the lamellipodial leading edge (Reinhard et al., 1992, 
1995; Bear et al., 2002; Gateva et al., 2014). It is unclear how formins 
and Ena/VASP work together in filopodia assembly (Yang et al., 
2007; Homem and Peifer, 2009; Barzik et al., 2014; Bilancia et al., 
2014).
In this study, we use a simple cellular system to examine funda-
mental features of formin-mediated filopodial assembly, using con-
stitutively active constructs of the formins mDia2 and FMNL3. These 
data suggest that any cluster of actin filament barbed ends in prox-
imity to the plasma membrane can serve as the starting material for 
formin-mediated filopodial assembly.
RESULTS
Filopodial assembly requires Arp2/3 complex 
in suspension cells
We used our previously developed Jurkat human T-cell system 
(Harris et al., 2010) to test whether Arp2/3 complex activity is neces-
sary for filopodial assembly by constitutively active formins. Jurkat 
cells grow in suspension and display ruffles as their predominant cell 
surface feature (Majstoravich et al., 2004; Figure 1A). As we previ-
ously observed, transfection with a green fluorescent protein (GFP)–
tagged construct containing the formin homology 1 (FH1) and FH2 
domains of FMNL3 (GFP-FMNL3-FF) or one containing the FH1, 
FH2, and C-terminal domains of mDia2 (GFP-mDia2-FFC; diagram 
in Supplemental Figure S1A) causes surface conversion from ruffles 
to filopodia, with GFP enriched at filopodial tips (Figure 1B and 
Supplemental Figure S1B). GFP-fusion expression level does not in-
fluence filopodial number significantly within the transfection range 
analyzed (Supplemental Figure S1C). The small molecule CK666 ef-
fectively inhibits Arp2/3 complex in these cells, as judged by inhibi-
tion of ruffles in untransfected cells (Figure 1A). In formin-transfected 
cells, CK666 has a dramatic effect on filopodia, reducing the per-
centage of cells displaying filopodia by 77 and 73% and the number 
of filopodia per cell by 96 and 95% for FMNL3 and mDia2, respec-
tively (Figure 1, C and D).
CK666 has a similar effect on GFP-FMNL3-FF–induced filopo-
dia in a second suspension cell line, 300.19 murine pre–B lym-
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FIGURE 1: Arp2/3 complex inhibition effectively ablates formin-mediated filopodia in suspension cells. 
(A) Representative micrographs of untransfected Jurkat T-cells treated in suspension for 2 h with DMSO (left) or 200 μM 
Arp2/3 complex inhibitor CK666 (right) and stained with TRITC-phalloidin (red). Cells were fixed in suspension before 
adhesion to PLL-coated coverslips. Arrowheads represent actin-rich membrane ruffles in DMSO control. Scale bar, 
10 μm. (B) Representative micrographs of GFP-FMNL3-FF–transfected Jurkat T-cells treated in suspension for 2 h with 
DMSO (left) or 200 μM CK666 (right). Similar micrographs for mDia2-FFC are shown in Supplemental Figure S1B. Cells 
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(2.6%) or shafts (21.1%; n = 76 filopodia), whereas GFP-FMNL3-FF is 
present at 100% of filopodial tips (Figure 5E). These results suggest 
that VASP’s role in formin-mediated filopodial assembly differs be-
tween suspension and adherent cells and that its primary role might 
not be at filopodial tips.
A population of FMNL3-mediated filopodia associates 
with focal adhesions
The effects of mDia1 and VASP in adherent cells raise the possibility 
that some filopodia might require actin filaments that are associated 
with focal adhesions. We investigated the relationship between 
GFP-FMNL3-FF–mediated filopodia and focal adhesions by stain-
ing fixed cells for paxillin and actin filaments and scoring filopodia/
focal adhesion association at the leading edge. Although the focal 
adhesion density at the leading edge varies, a disproportionately 
high percentage of filopodia originates at focal adhesions, even in 
cells for which focal adhesion density is low (Figure 6, A and B). We 
also imaged live cells cotransfected with GFP-FMNL3-FF and either 
mApple-vinculin (Figure 6D and Supplemental Movie S3) or mRFP-
paxillin (Figure 6E and Supplemental Movie S4). Puncta of GFP-
FMNL3 appear to extend directly from the focal adhesion in both 
cases. We quantified the percentage of focal adhesion–associated 
filopodia from confocal movies and found a similar trend as in fixed 
cells (Figure 6C). These results suggest that a population of filopo-
dia emanates directly from focal adhesions in these cells.
The myosin II inhibitor blebbistatin causes a reduction in focal 
adhesions and stress fibers (Hotulainen and Lappalainen, 2006; 
Aratyn-Schaus et al., 2011). We tested whether blebbistatin treat-
ment would influence filopodia assembly in U2OS and 3T3 cells. 
Surprisingly, blebbistatin does not reduce filopodial number 
(Figure 7A), despite causing a significant reduction in stress fibers. 
We observe, however that blebbistatin causes a significant increase 
in filopodial length in both U2OS and 3T3 cells (Figure 7B). This 
effect is likely due to the function of myosin II on retrograde flow 
and has been observed in other systems (Medeiros et al., 2006; 
Shin et al., 2014). An interesting feature is that, upon blebbistatin 
treatment, filopodia appear to emanate throughout the cell pe-
riphery, whereas they are largely confined to the protruding ends 
of untreated cells (Figure 7C).
DISCUSSION
In this work, we use a relatively simple system, expression of consti-
tutively active formin proteins, to ask fundamental questions about 
filopodial assembly. Collectively our results show that Arp2/3 com-
plex is an important nucleation factor in formin-mediated filopodial 
assembly. However, we also show that a population of filopodia 
remains after Arp2/3 complex inhibition in adherent cells and that 
filopodia frequently assemble from focal adhesions. We therefore 
constructs of the formin mDia1 did not induce filopodia (Harris 
et al., 2010). However, other studies have shown a role for mDia1 in 
filopodia assembly (Sarmiento et al., 2008; Goh et al., 2011; Naj 
et al., 2013), in addition to its roles in stress fiber and focal adhesion 
assembly (Watanabe et al., 1999; Hotulainen and Lappalainen, 
2006; Zaoui et al., 2008; Fan et al., 2010; Rao et al., 2013; Burnette 
et al., 2014) in a variety of cell types. Given that a difference be-
tween adherent and suspension cells is the presence of stress fibers 
and focal adhesions, we postulated that mDia1 might contribute to 
filopodia assembly only in adherent cells.
We tested mDia1’s role by siRNA depletion in U2OS cells (∼87% 
mDia1 depletion; Supplemental Figure S5A). Depletion of mDia1 
reduces filopodia number by a comparable amount to Arp2/3 com-
plex inhibition (78% reduction for FMNL3-FF and 64% reduction for 
mDia2-FFC; Figure 3A), and reduces the percentage of cells pos-
sessing filopodia to a greater degree than Arp2/3 complex inhibi-
tion (34 and 15% decrease for FMNL3 and mDia2, respectively; 
Figure 3B). When combining mDia1 depletion with Arp2/3 inhibi-
tion (through CK666 treatment), both the number of filopodia per 
cell and the percentage of cells displaying filopodia are reduced 
further than with either treatment alone (Figure 3). However, a small 
population of filopodia persists under combined mDia1 and Arp2/3 
complex inhibition. Micrographs representative of some of these 
conditions are shown in Supplemental Figure S5B. Collectively 
these data suggest that both mDia1 and Arp2/3 complex play roles 
in the majority of filopodial assembly in adherent cells.
We also examined the role of mDia1 in filopodia assembly in 
suspension cells. Of interest, mDia1 depletion does not reduce the 
percentage of cells with filopodia (100% of cells have filopodia; un-
published data), or the number of filopodia per cell (Figure 4B). 
However, mDia1 depletion does cause a significant increase in the 
number of “forked” filopodia (filopodia that originate from a com-
mon origin; Figure 4, A and C). These results suggest that the role 
of mDia1 in filopodial assembly is different between adherent and 
suspension cells.
VASP is another actin assembly factor that has been linked to fi-
lopodia in many studies (Svitkina et al., 2003; Lebrand et al., 2004; 
Applewhite et al., 2007). We therefore examined the role of VASP in 
our system. In U2OS cells, endogenous VASP enriches at focal ad-
hesions, but only enriches at the tips of a subset of filopodial tips, 
which appear to contain less GFP-FMNL3 (Figure 5A). In Jurkat cells, 
we find no specific localization of endogenous VASP in the cell body 
or in FMNL3-assembled filopodia (Figure 5B). Of interest, overex-
pression of mApple-VASP has opposite effects in suspension and 
adherent cells, decreasing the number of GFP-FMNL3-FF–contain-
ing filopodia in Jurkat cells by 44% but increasing these filopodia in 
U2OS cells by 59% (Figure 5, C and D). Despite this increase in 
U2OS filopodia, mApple-VASP is rarely enriched in filopodial tips 
were adhered to PLL-coated coverslips for 10 min before fixation. Actin is stained with TRITC-phalloidin (red), and 
GFP-FMNL3-FF is green. Arrowhead indicates FMNL3 enriched at filopodial tip. Filopodia number in examples: DMSO, 
13; and CK666, 0. Scale bar, 10 μm. (C) Quantification of percentage of transfected cells displaying filopodia after 
indicated treatment. (D) Quantification of filopodia per transfected cell after indicated treatment. Results are pooled 
from three to five independent experiments, 55–80 cells (FMNL3) and 34–68 cells (mDia2). (E) Representative 
micrographs of 300.19 cells untransfected and treated with DMSO showing no filopodia (left) and transfected with 
GFP-FMNL3-FF and treated with 200 μM inactive CK689 control (middle) or 200 μM Arp2/3 complex inhibitor CK666 
(right). All cells were treated in suspension for 2 h, followed by 10 min of adhesion onto PLL-coated coverslips before 
paraformaldehyde fixation. Actin is stained with TRITC-phalloidin (red) and DNA with DAPI (blue), and GFP-FMNL3-FF is 
green. Arrowhead indicates FMNL3 enriched at the filopodial tip. Filopodia number in examples: CK689, 15; and 
CK666, 0. Scale bar, 5 μm. (F) Quantification of percentage of transfected cells displaying filopodia after the indicated 
treatment. (G) Quantification of filopodia number per transfected cell treated as indicated. Results are pooled from 
three to five independent experiments (except for CK689, one experiment); 51–133 cells. Error bars, SD. ***p < 0.001.
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FIGURE 2: Arp2/3 complex inhibition reduces formin-mediated filopodia in adherent cells. (A) Representative 
micrographs of U2OS cells transfected with GFP-mDia2-FFC and treated for 2 h with 200 μM CK689 (left) or 200 μM 
CK666 (right). Actin is stained with TRITC-phalloidin (red), and GFP-mDia2-FFC is green. Arrowheads indicate mDia2 
enriched at filopodial tips. Filopodia number in insets: GFP/DMSO, 0; mDia2/CK689, 10; and mDia2/CK666, 5. 
Examples of untreated U2OS cells transfected with GFP alone in Supplemental Figure S3. (B) Quantification of 
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ing Arp2/3 complex–nucleated dendritic network (convergent elon-
gation; Figure 8A), formin-nucleated filaments (tip nucleation; 
Figure 8B), formin-nucleated filaments in which the nucleating for-
min is displaced by a bundling formin (indirect tip nucleation; Figure 
8C), and a sequential combination of formin- and Arp2/3 complex–
mediated nucleation (extended convergent elongation; Figure 8D).
Much of the uncertainty surrounding filopodial assembly con-
cerns the identity of the actin nucleation involved (Chhabra and 
Higgs, 2007; Faix et al., 2009; Harris et al., 2010). In principle, formin 
proteins can serve as both nucleation and elongation factors, mak-
ing the tip nucleation model intuitively attractive. In practice, how-
ever, at least two filopodia-assembling formins, FMNL3 and DAAM1, 
are extremely poor actin-nucleating proteins in vitro (Heimsath and 
Higgs, 2012; Jaiswal et al., 2013), suggesting that these formins 
might not necessarily nucleate filopodial actin filaments.
Arp2/3 complex clearly plays a major role in filopodial assembly 
in all cells we analyzed, suggesting that convergent elongation is an 
important assembly mechanism. In adherent cells, however, a popu-
lation of filopodia remains upon Arp2/3 complex inhibition, sug-
gesting the existence of other assembly mechanisms. We find that 
inhibition of another potential nucleation factor, mDia1, reduces fi-
lopodia in adherent cells. Other studies have linked mDia1 with filo-
podia (Sarmiento et al., 2008; Goh et al., 2011, 2012; Naj et al., 
2013), but its specific function has been unclear.
What is the mechanistic explanation for both Arp2/3 complex 
and mDia1 acting in filopodial assembly in adherent cells? The sim-
plest scenario is that two independent pathways exist by which filo-
podia could assemble from either linear mDia1-generated filaments 
(Figure 8C) or branched Arp2/3 complex–generated filaments 
(Figure 8A). There has long been evidence for distinct actin networks 
existing at the leading edge of adherent cells, one being the Arp2/3 
complex–assembled dendritic network and the other being less de-
fined. In addition to ventral stress fibers, there may be a network of 
longer filaments ventral to the lamellipodium in some cells (Ponti 
et al., 2004; Giannone et al., 2007; Urban et al., 2010). Yet another 
population of filaments called dorsal stress fibers originates at focal 
adhesions (Hotulainen and Lappalainen, 2006; Burnette et al., 2014).
We favor dorsal stress fibers as a possible second source of fila-
ments for filopodial assembly. Current evidence suggests that dor-
sal stress fibers consist of uniformly oriented actin bundles that re-
quire mDia1 for assembly but do not contain significant myosin II 
(Hotulainen and Lappalainen, 2006; Oakes et al., 2012; Burnette 
et al., 2014). These findings agree well with our results correlating 
the majority of filopodia with focal adhesions, as well as with the fi-
lopodial inhibition we observe upon mDia1 suppression but not 
upon myosin II inhibition. Of interest, myosin II inhibition did result 
in the loss of filopodial polarity (Figure 7C). Another source of fila-
ments might be the cortical actin network, since this network re-
quires both Arp2/3 complex and mDia1 (Bovellan et al., 2014). 
However, the lack of effect of mDia1 suppression in Jurkat cells, 
which should have a cortical actin network, argues against this 
possibility.
propose a modification to existing assembly models: filopodia can 
assemble from any collection of barbed ends in proximity to the 
plasma membrane, not just from the lamellipodial network. These 
filaments might be nucleated by a number of mechanisms, includ-
percentage of transfected cells displaying filopodia after the indicated treatment. (C) Quantification of filopodia number 
on transfected cells treated as indicated. Results are pooled from three or four independent experiments, 24–37 cells 
(FMNL3) and 92–141 cells (mDia2). (D) Representative micrographs of NIH 3T3 cells transfected with GFP-FMNL3-FF 
and then treated for 2 h with DMSO (left) or 200 μM CK666 (right). Actin is stained with TRITC-phalloidin (red) and DNA 
with DAPI (blue), and GFP-FMNL3-FF is green. Arrowheads indicate FMNL3 enriched at filopodial tips. Filopodia 
numbers in insets: DMSO, 9; and CK666, 2. Scale bar, 10 μm (main image) and 5 μm (insets). (E) Quantification of 
percentage of transfected cells displaying filopodia after indicated treatment. (F) Quantification of filopodia number on 
each transfected cell after the indicated treatment. Results are pooled from three to five independent experiments; 
48–118 cells. Scale bars: 10 μm (main image) and 5 μm (insets). Error bars, SD. ***p < 0.001.
FIGURE 3: mDia1 depletion reduces formin-mediated filopodia in 
adherent cells. U2OS cells were transfected for 72 h with the 
indicated siRNA (control, mDia1 targeting, or Arp2 targeting). At 48 h 
after siRNA transfection, cells were transfected with either GFP-
FMNL3-FF or GFP-mDia2-FFC and treated for 2 h with DMSO or 
200 μM CK666. (A) Quantification of filopodia number per transfected 
cell after the indicated treatment. Results with CK666 differ from 
DMSO control with p < 0.001 for all but the Arp2 siRNA, mDia2-
transfected results (p = 0.003). (B) Percentage of GFP-FMNL3-FF 
or GFP-mDia2-FFC transfected cells displaying filopodia after the 
indicated treatment. Results with CK666 differ from DMSO control 
with p > 0.1 for all conditions. Results are pooled from three of four 
independent experiments; 88–124 cells (FMNL3) and 79–127 cells 
(mDia2). Error bar, SD.
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Why does a population of filopodia remain after inhibition of 
both mDia1 and Arp2/3 complex in adherent cells? Possibilities in-
clude the following: 1) there is a low level of tip nucleation activity 
directly by FMNL3 or mDia2 (Figure 8B), 2) other nucleating activi-
ties occur near the cortex, either other formins or the WH2-contain-
ing proteins Spire or Cordon Bleu, and 3) residual mDia1 protein 
and/or Arp2/3 complex activity might be sufficient to maintain a low 
degree of filopodial assembly.
Our results show that VASP’s role on FMNL3-mediated filopodia 
differs between suspension and adherent cells. In neither cell type 
do we find consistent VASP enrichment at filopodial tips. The role of 
Ena/VASP proteins in filopodia assembly has been unclear. Ena/
VASP has been implicated in filopodial assembly in several cellular 
systems (Han et al., 2002; Svitkina et al., 2003; Schirenbeck et al., 
2006; Kwiatkowski et al., 2007) and is found at the tips of or along 
the shafts of filopodia in some systems (Lanier et al., 1999; Rottner 
et al., 1999; Schirenbeck et al., 2006; Gates et al., 2007). VASP inter-
acts directly with filopodia-assembling formin proteins in Dictyoste-
lium (Schirenbeck et al., 2006), Drosophila (Homem and Peifer, 
2009), and mammals (Grosse et al., 2003; Barzik et al., 2014) and 
might potentiate elongation of formin-mediated filopodia (Barzik 
et al., 2014). In addition, elegant studies in Drosophila suggest that 
the functional interplay between VASP and formins is intricate and 
has major consequences for development (Homem and Peifer, 
2009; Bilancia et al., 2014).
However, it is not clear in all systems that VASP contributes di-
rectly to filopodial assembly. VASP also localizes to other areas, such 
as focal adhesions (Reinhard et al., 1992; Bear et al., 2000, 2002; 
Grosse et al., 2003), dorsal stress fibers (Gateva et al., 2014), and 
the leading edge in general (Rottner et al., 1999). A recent study in 
adherent cells showed that VASP rarely enriched at filopodial tips in 
the presence of constitutively active mDia2 but did increase the 
lifetime of these filopodia (Barzik et al., 2014). These results are 
similar to ours and might suggest that at least part of VASP’s effect 
on filopodia could be due to the VASP population in the focal adhe-
sions, perhaps either through increased assembly of dorsal stress 
fibers (Gateva et al., 2014) or through increased substrate adhesion 
(Schafer et al., 2009).
The behavior of full-length formins might differ somewhat from 
our simple system, which uses formin constructs lacking the N-ter-
minal regulatory region. In both mDia and FMNL family proteins, 
this region contains a Rho GTPase–binding domain, autoinhibitory 
DID domain (sometimes referred to as FH3), and a dimerization do-
main (Wallar et al., 2006; Kuhn et al., 2015) and participates in cel-
lular localization through interactions with other proteins (Seth et al., 
2006; Brandt et al., 2007). The interaction and possible competition 
between endogenous formins and the expressed formin constructs 
at filopodial tips might also contribute to the effects observed here. 
Further studies with full-length formins in more defined endogenous 
formin backgrounds will be useful in testing our proposed models.
A final question pertains to how our simple system relates to 
other filopodial systems. In cell lines in which Arp2/3 complex sub-
units are either suppressed (Steffen et al., 2006; Gomez et al., 2007; 
Wu et al., 2012) or ablated (Suraneni et al., 2012), assembly of 
endogenous filopodia still occurs. These filopodia appear to be 
enriched in mDia1 and mDia2 (Suraneni et al., 2012) and are formin 
dependent (Suraneni et al., 2015). These studies provide evidence 
for an Arp2/3 complex–independent filopodial assembly mecha-
nism. Given the variety of filopodia-like structures that exists, it is 
certainly possible that multiple variations on either convergent elon-
gation or tip nucleation might be used. In addition, there may be 
formin-independent mechanisms of filopodial assembly. Our study 
An argument against the existence of two independent filopo-
dial nucleation pathways is the fact that inhibition of either Arp2/3 
complex or mDia1 individually results in >50% reduction in filopo-
dia number, whereas one might expect the sum of these effects to 
be no more than 100% if in independent pathways. A second pos-
sibility is that mDia1 and Arp2/3 complex act together in the same 
pathway to supply filaments that can be used by bundling formins 
such as FMNL3 and mDia2. For example, Arp2/3 complex could 
elaborate a branched network from mDia1-assembled dorsal stress 
fibers, which can be organized into filopodia by bundling formins 
(Figure 8D).
FIGURE 4: mDia1 depletion does not reduce FMNL3-mediated 
filopodia in Jurkat T-cells. (A) Representative images of Jurkat T-cells 
transfected for 72 h with control (left) or mDia1-targeting siRNA 
(right), followed by transfection with GFP-FMNL3-FF for the final 24 h. 
Cells were adhered to PLL-coated coverslips for 10 min before 
paraformaldehyde fixation. Actin is stained with TRITC-phalloidin (red), 
and FMNL3 is green. Insets provide examples of filopodia originating 
from a common base. Images are maximum intensity projections from 
25 × 0.2–μm Z-slices. Scale bar, 10 μm (main image) and 2 μm (insets). 
(B) Quantification of filopodia per transfected cell after the indicated 
treatment. Results are pooled from four independent experiments; 
104–118 cells. Error bar, SD. p = 0.09. (C) Quantification of percentage 
of filopodia that originate from a common base after the indicated 
treatment. Results are pooled from four independent experiments; 
1317–1688 filopodia. Error bar, SD. ***p < 0.001.
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Carlsbad, CA) supplemented with 5% fetal bovine serum (FBS; 
Atlanta Biologicals, Norcross, GA), 2 mg/ml glucose, 1 mM so-
dium pyruvate (Life Technologies), and 50 μM β-mercaptoethanol 
(Life Technologies). Murine 300.19 pre–B lymphoma cells (a gift 
from Geoffrey Kansas, Northwestern Medical School, Chicago, IL) 
were grown in RPMI supplemented with 5% FBS and 50 μM β-
mercaptoethanol. Both Jurkat and 300.19 cells were maintained 
in suspension at concentrations of <1 million cells/ml. Mouse NIH 
shows that a diverse array of actin filament sources, not simply the 
lamellipodial network, is capable of serving as a precursor for for-
min-mediated filopodia.
MATERIALS AND METHODS
Cell culture
Human Jurkat T lymphocytes (American Type Culture Collection, 
Manassas, VA) were grown in RPMI 1640 (Life Technologies, 
FIGURE 5: Effect of VASP on formin-mediated filopodial assembly differs between suspension and adherent cells. 
(A, B) Endogenous VASP (white) staining by immunofluorescence microscopy of U2OS cells (A) or Jurkat cells 
(B) transfected with GFP-FMNL3-FF (green). Red for U2OS cells is endogenous paxillin and for Jurkat cells indicates 
actin filaments (TRITC-phalloidin). Arrows indicate two filopodia with some degree of VASP at tips. Scale bar, 2 μm. 
(C) Quantification of filopodia number per transfected U2OS cell after transfection with mApple-VASP, GFP-FMNL3-FF, 
or mApple-VASP and GFP-FMNL3-FF; 20–25 cells. Error bar, SD. **p < 0.01. (D) Quantification of filopodia number per 
transfected Jurkat cell after transfection with mApple-VASP, GFP-FMNL3-FF, or mApple-VASP and GFP-FMNL3-FF; 
30–87 cells. Error bar, SD. ***p < 0.001. (E) Fluorescence micrographs of mApple-VASP (white), GFP-FMNL3-FF (green), 
and BFP-Lifeact (red) in U2OS cells, showing examples of VASP enrichment in filopodial shaft (left), VASP enrichment in 
filopodial tip (middle), or no VASP enrichment in filopodia (right). Scale bar, 1 μm.
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3T3 cells (a gift from Gregg Gundersen, 
Columbia University, New York, NY) and 
cultured in DMEM with 4.5 g/l glucose, l-
glutamine, sodium pyruvate, and 10% 
neonatal calf serum (NCS; Atlanta Biologi-
cals). U2OS human osteosarcoma cells (a 
gift from Duane Compton, Geisel School 
of Medicine, Dartmouth College, Hanover, 
NH) and cultured in DMEM with 4.5 g/l 
glucose, l-glutamine, sodium pyruvate, 
and 10% NCS (Atlanta Biologicals).
DNA transfections
For 300.19 and 3T3 cells, DNA constructs 
were introduced by electroporation. 
Briefly, cells were washed twice in phos-
phate-buffered saline (PBS) and resus-
pended to 12.5 × 106 cells/ml in PBS. 
Cells, 400 μl, were mixed with 20 μg of 
plasmid DNA in a 4-mm gap electropora-
tion cuvette (BTX Harvard Apparatus) and 
electroporated at 250 V and 975-μF ca-
pacitance in a Gene Pulser II (Bio-Rad, 
Hercules, CA). Prewarmed medium (1 ml) 
was added, and cell debris was removed. 
For 3T3 cells, cells were moved to 4-ml 
prewarmed medium, centrifuged at 300 × 
g for 5 min, and seeded onto glass cover-
slips at 1 × 105 cells/ml. Cells were incu-
bated for 24 h before treatment and fixa-
tion. For 300.19 cells, cells were added to 
6 ml of prewarmed medium and left at 
37°C/5% CO2 for 6 h. Cells were centri-
fuged at 300 × g for 5 min, and the cell 
pellet was brought up in 1 ml of pre-
warmed medium. A 0.5-ml amount of sus-
pension was placed on a 12-mm round 
coverslip coated with 0.01% poly-l-lysine 
(PLL; >300,000 molecular weight; Sigma-
Aldrich, St. Louis, MO) and incubated for 
10 min before fixation.
For U2OS cells, DNA constructs were in-
troduced using JetPrime transfection re-
agent (PolyPlus, Illkirch, France); a total of 
0.5 μg of each plasmid DNA was used for all 
transfections. Cells were incubated for 24 h 
before treatment and fixation.
For Jurkat T-cells, DNA constructs 
were introduced using the Amaxa Nu-
cleofector Kit (Lonza, Cologne, Germany). 
Before nucleoporation, 1 × 106 cells were 
centrifuged at 300 × g for 10 min, resus-
pended in 100 μl of Nucleofector solution 
FIGURE 6: A subset of FMNL3-FF–mediated filopodia associates with focal adhesions. 
(A) Representative micrograph of the leading-edge region of a U2OS cell cotransfected with 
RFP-paxillin (white), BFP-Lifeact (red), and GFP-FMNL3-FF (green). Images are maximum 
intensity projections from 10 × 0.2–μm Z-slices. Arrowheads indicate two filopodia that are not 
associated with focal adhesions in this example. Scale bar, 0.5 μm. (B) Quantification of 
percentage of FMNL3-FF–enriched filopodia that are associated with focal adhesions (judged 
from fixed cells stained with anti-paxillin) as a function of percentage of focal adhesion coverage 
at the leading edge; 7 cells. See Materials and Methods for description of quantification. 
(C) Quantification of focal adhesion–associated filopodia from confocal movies similar to D. 
(D) Time-lapse montage of FMNL3 punctum emanating from a focal adhesion (individual time 
points from Supplemental Movie S3). U2OS cells cotransfected with mApple-vinculin (red) and 
GFP-FMNL3-FF (green). mApple and GFP micrographs were acquired sequentially (<1 s 
between colors) every 30 s. Scale bar, 2 μm. (E) Structured illumination microscopy time-lapse 
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The following expression constructs 
were used: pEGFP-C1 FMNL3-FF (Harris 
et al., 2010), pEGFP-C1 mDia2-FFC (Harris 
et al., 2010), mApple VASP-5 (Addgene; a 
gift from Michael Davidson, Florida State 
University, Tallahassee, FL), mApple vinculin 
(a gift from Clare Waterman, National Insti-
tutes of Health, Bethesda, MD), mRFPn 
paxillin (a gift from Scott Blystone, Upstate 
Medical University, Syracuse, NY), F-tractin 
mCherry fusion (a gift from Clare Water-
man, National Institutes of Health) and 
mTagBFP2-Lifeact7 (a gift from Michael 
Davidson).
Inhibitor treatment
Cells were treated with inhibitors for 2 h at 
37°C/5% CO2 (unless otherwise stated). All 
inhibitors were diluted from dimethyl sulfox-
ide (DMSO) stocks (Sigma-Aldrich) to the 
following concentrations in full cell medium: 
CK666 or CK689 to 200 μM (Calbiochem, 
Billerica, MA) and blebbistatin to 50 μM 
(Sigma-Aldrich).
siRNA treatment
For U2OS cells, 50 nM each siRNA oligo-
nucleotide was introduced using Lipo-
fectamine RNAiMAX following the manu-
facturer’s instructions. Cells were analyzed 
72 h posttransfection. For Jurkat T-cells, 
1 μM each siRNA oligonucleotide was in-
troduced using the Amaxa Nucleofector 
Kit V. Cells were analyzed 72 h posttrans-
fection. Oligonucleotides for siRNA in-
cluded human Arp2 (IDT, Integrated DNA 
Technologies, Coralville, IA; CGAUCAAU-
GUUAGAAUUAACUACC), human mDia1 
(Ambion, Waltham, MA; GGAGUUACGAU-
AGCCGGAA), and negative control (IDT; 
CGUUAAUCGCGUAUAAUACGCGUAT).
Western blotting
Cells were extracted 72 h posttransfec-
tion. U2OS cells were scraped with 100 μl 
of 2× DB (50 mM Tris-HCl, pH 6.8, 2 mM 
EDTA, 20% glycerol, 0.8% SDS, 0.02% 
bromophenol blue, 1000 mM NaCl, 4 M 
urea). Jurkat T-cells (∼1 × 106 cells) were 
resuspended in 100 μl of 2× DB. Proteins 
were separated by 7.5% SDS–PAGE and 
transferred to a polyvinylidene fluoride 
membrane (Millipore, Billerica, MA). The 
membrane was blocked with TBS-T 
(20 mM Tris-HCl, pH 7.6, 136 mM NaCl, 
and 0.1% Tween-20) containing 3% bovine 
serum albumin (Research Organics, Cleveland, OH) for 1 h and 
then incubated with primary antibody at 4°C overnight. After 
washing with TBS-T, the membrane was incubated with horserad-
ish peroxidase–conjugated secondary antibody (Bio-Rad) for 2 h 
at room temperature. Protein signal was detected by chemilumi-
nescence, and Western band intensity was quantified using 
V, and mixed with 2 μg of plasmid. Resuspended cells were 
nucleoporated using the program X-001 (Nucleofection 2b 
Device), and 500 μl of full medium was added. Cells were trans-
ferred to a 12-well plate containing 1 ml of prewarmed medium 
and incubated at 37°C/5% CO2 for up to 8 h before treatment 
and fixation.
FIGURE 7: Myosin II inhibition does not reduce filopodia number but increases filopodial length. 
U2OS cells or NIH 3T3 cells were transfected with GFP-FMNL3-FF (both cell types) or GFP-
mDia2-FFC (U2OS only) and treated for 2 h with DMSO or 50 μM blebbistatin. (A) Quantification 
of filopodia number per transfected cell treated as indicated. Results are pooled from three or 
four independent experiments; 31–103 U2OS cells, 83–117 NIH 3T3 cells. Error bar, SD. 
*p < 0.05, ***p < 0.001. (B) Quantification of filopodial length in GFP-FMNL3-FF– or GFP-
mDia2-FFC–transfected cells. Results are pooled from three or four independent experiments; 
40–95 filopodia in U2OS cells, 297–423 filopodia in 3T3 cells. Error bar, SD. ***p < 0.001. 
(C) Representative micrographs of U2OS cells transfected with GFP-FMNL3 and treated with 
DMSO (left) or 50 μM blebbistatin (right). Scale bar, 10 μm (main image) and 5 μm (insets).
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for at least 1 h. Before fixation, 300.19 and Jurkat T-cells were al-
lowed to settle on coverslips precoated with 0.1% PLL for 10 min 
at 37°C. To fix Jurkat T-cells in suspension, 3 × 106 cells were fixed 
in 4% paraformaldehyde in PBS (1 ml) for at least 1 h at room tem-
perature. Fixed cells were resuspended in PBS (100 μl/coverslip) 
and then allowed to settle onto coverslips precoated with 0.1% 
PLL for 10 min at 37°C, followed by a further 10 min of incubation 
in 4% paraformaldehyde.
U2OS and 3T3 cells were fixed on 12-mm round coverslips 
by removal of medium and addition of 4% formaldehyde in PBS 
for 20 min.
ImageJ (National Institutes of Health, Bethesda, MD). Primary 
antibodies used were anti-mDia1 produced in chicken (Aves 
Labs, Tigard, OH) using amino acids 748–1175 of mouse mDia1 
as antigen, followed by affinity purification against the same anti-
gen; anti–inverted formin-2 (Ramabhadran et al., 2011); anti-tu-
bulin (DM1-α; Sigma-Aldrich); and anti-Arp2 (H-84; Santa Cruz 
Biotechnology, Dallas, TX).
Immunofluorescence microscopy
300.19 and Jurkat T-cells were fixed on 12-mm round coverslips by 
removal of medium and addition of 4% paraformaldehyde in PBS 
FIGURE 8: Models for filopodial assembly. Models A (convergent elongation) and B (tip nucleation) were proposed 
previously. We propose models C and D from our results in this work. (C) Indirect tip nucleation model. A nucleation 
factor (e.g., mDia1) assembles new filaments at a specific site near the leading edge (purple oval), such as a focal 
adhesion. During filament elongation, the barbed end–bound nucleation factor is displaced by a bundling formin 
(e.g., FMNL3 or mDia2), which allows further elongation, as well as bundling, to drive productive filopodial growth. 
(D) Extended convergent elongation model. Actin filaments are assembled at a specific site (purple oval) by a nucleation 
factor such as mDia1 and serve as mother filaments for Arp2/3 complex–mediated nucleation. Bundling formins such as 
FMNL3 and mDia2 then mediate convergent elongation on the Arp2/3 complex–nucleated barbed ends. We do not 
depict VASP in these models because its role is still unclear, but it could in principle be enhancing the initial assembly of 
filaments in models A, C, and D.
Convergent elongation 
Tip nucleation 
Indirect tip nucleation 
Extended convergent elongation 
Barbed end 
Bundling formin 
(FMNL3 or mDia2) 
Capping protein 
Arp2/3 complex 
Actin filament 
Pointed end 
A 
B 
C 
D 
mDia1 
Key 
Volume 26 December 15, 2015 Filopodial assembly by formins | 4657 
Quantification methods
NIS-Elements software was used for all analysis.
For quantification of fixed-cell phenotypes, FMNL3/mDia2-
dependent filopodia were quantified on cells transfected with 
GFP-FMNL3-FF or GFP-mDia2-FFC and stained with TRITC-phal-
loidin. Filopodia were positive when GFP was found at the tip of 
an actin-stained thin protrusion (width of protrusion at or near 
the resolution limit, ∼200 nm) from the cell body. Filopodial 
length was measured from the central point of the tip-localized 
GFP punctum to the interface between the protrusion and the 
cell body.
For quantification of GFP fluorescence intensity versus filopodia 
number, total GFP fluorescence intensity of 10 randomly selected 
cells for GFP-FMNL3-FF–transfected Jurkat T-cells was normalized 
by subtracting background fluorescence from areas devoid of cells. 
Filopodia number per cell was counted manually and plotted as a 
function of GFP fluorescence intensity. Results are shown in Supple-
mental Figure S1C.
For focal adhesion quantification, GFP-FMNL3-FF–transfected 
U2OS cells were stained for paxillin (anti-paxillin) and actin fila-
ments (TRITC-phalloidin). Leading-edge length was measured by 
tracing the edge of the cell body (following the phalloidin signal). 
Filopodia were excluded from the trace. Focal adhesion coverage 
was calculated by measuring the width of paxillin staining at the 
leading edge; the sum of all widths was divided by the total lead-
ing-edge length to obtain the percentage of focal adhesion cover-
age. Maximum intensity projections of confocal-acquired images 
were used to trace the phalloidin signal back from the GFP-la-
beled filopodial tip to the cell body. Analysis of live-cell filopodia 
and focal adhesion association was done in a similar manner. 
U2OS cells were cotransfected with BFP-Lifeact, RFP-paxillin, and 
GFP-FMNL3-FF.
Quantification of filopodia lifetimes and maximum filopodial 
length was done in a 10-μm region of the leading edge from time-
lapse series of 10–15 min. Quantification of the filopodia birth rate 
was done in a 10-μm region of the leading edge in a 5-min acquisi-
tion time.
Electron microscopy
The 300.19 cells were fixed for 1–2 h in 3.5% glutaraldehyde in 
100 mM NaPO4, pH 7.4. Suspension cells were adhered to PLL 
coating by allowing fixed cells to settle onto coverslips (as 
described for immunofluorescence), followed by refixing. Cover-
slips were washed with 20 mM sodium phosphate and stained for 
1 h with 1% osmium tetroxide (Electron Microscopy Sciences, 
Hatfield, PA) diluted in 100 mM sodium phosphate (pH 6.0). Cov-
erslips were washed once in water and dehydrated sequentially 
with 30, 50, 70, 95, and 100% ethanol (>10-min incubation in 
each). Coverslips were washed 2 × 5 min with 1:1 and 1:2 dilu-
tions of ethanol:hexamethyldisilazane (HMDS; Sigma-Aldrich) 
and then 3 × 20 min with 100% HMDS. Coverslips were dried 
overnight in a desiccator under vacuum. Before viewing, 
coverslips were adhered to aluminum SEM stubs (Electron Mi-
croscopy Sciences) and coated with 3 nm of osmium tetroxide 
using an OPC-60 Osmium Plasma Coater (SPI Supplies, West 
Chester, PA). Cells were imaged in SE mode with an FEI XL-30 
FEG ESEM using an accelerating voltage of 5 kV and spot size of 
3. Quantification of SEM images was done using low-magnifica-
tion images (1000×) to evaluate percentage of cells with filopo-
dia. Six randomly selected fields of view with 76–108 cells were 
counted. From these images, filopodia per cell number was eval-
uated from those cells that contained at least one filopodium.
For staining, all cells were washed in 3× PBS before permeabili-
zation with 0.1% Triton X-100 in PBS for 15 min. Cells were washed 
3× with PBS and incubated in blocking buffer (10% calf serum, 0.1% 
saponin, 0.02% sodium azide in PBS) for 30 min. Cells were stained 
with combinations of the following: primary antibody (described 
later), 1 mM tetramethylrhodamine isothiocyanate (TRITC)–phalloi-
din (Sigma-Aldrich), and 0.4 ng/μl 4′,6-diamidino-2-phenylindole 
(DAPI) in block solution diluted 1:10 in PBS for 1 h at room tempera-
ture. Cells were incubated with primary treatment for 1 h, followed 
by 3× PBS washes and incubation in secondary antibody for 1 h. 
Cells were washed 3× with PBS and mounted on polyvinyl alco-
hol–1,4-diazabicyclo[2.2.2]octane.
Images were acquired using a Nikon TE-2000E microscope with 
either the 60×/1.4 numerical aperture (NA) or 100×/1.4 NA objec-
tive, a Roper CoolSnap camera, and Nikon Elements software. Alter-
natively, images where maximum intensity projections are shown 
(see figure legends) were acquired using a Wave FX spinning-disk 
confocal microscope (Quorum Technologies, Sussex, UK; on a Nikon 
Eclipse microscope) with Z-stacks of 0.2-μm sections.
Primary antibodies were monoclonal anti-paxillin (610569; BD 
Biosciences, San Jose, CA) and monoclonal anti-VASP 9A2 (3132; 
Cell Signaling, Danvers, MA). Secondary antibodies were Alexa Fluor 
405–conjugated anti-mouse immunoglobulin G (IgG; Invitrogen, 
Carlsbad, CA), Texas red anti-mouse IgG (Vector Laboratories, Burl-
ingame, CA), and Alexa Fluor 405–conjugated anti-rabbit IgG 
(Invitrogen).
Live-cell microscopy
For live-cell acquisition, coverslips were mounted onto a flow 
chamber in live-cell medium (DMEM minus phenol red, 25 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 10% NCS) 
and then onto a Wave FX spinning-disk confocal microscope 
(Quorum Technologies, Guelph, Canada; on a Nikon Eclipse mi-
croscope) with Bionomic Controller (20/20 Technology, Montreal, 
Canada), and temperature-controlled stage set to 37°C. After 
equilibration to temperature for 10 min, cells were imaged 
through the 60×/1.4 NA Plan Apo objective (Nikon USA, Melville, 
NY) using the 403-nm laser and 435/485 filter for blue fluorescent 
protein (BFP), the 491-nm laser and 525/20 filter for GFP, and the 
561-nm laser and 593/40 filter for monomeric red fluorescent pro-
tein (mRFP)/mApple. For Supplemental Movies S1, S2, and S4, 
GFP and mRFP/mApple micrographs were acquired sequentially 
(< 1 s between channels) at 5-s intervals, For Supplemental Movie 
S3, GFP and mApple micrographs were acquired sequentially 
(<1 s between channels) at 30-s intervals. Inhibitor was added 2 h 
before live-cell analysis and was kept in cell medium during 
acquisition.
Superresolution three-dimensional structured illumination micro-
scopy images were acquired on a DeltaVision OMX V4 (GE Health-
care, Waterbury, VT) equipped with a 60×/1.42 NA PlanApo oil im-
mersion objective (Olympus, Center Valley, PA), 405-, 488-, 568-, 
and 642-nm solid-state lasers (100 mW), and sCMOS cameras (pco.
edge). Image stacks of 1 μm with 0.125-μm-thick Z-sections and 
15 images per optical slice (3 angles and 5 phases) were acquired 
using immersion oil with a refractive index of 1.524. Images were 
reconstructed using Wiener filter settings of 0.005 and optical trans-
fer functions measured specifically for each channel with SoftWoRx 
6.1.3 (GE Healthcare) to obtain superresolution images with a two-
fold increase in resolution both axially and laterally. Images from 
different color channels were registered using parameters gener-
ated from a gold grid registration slide (GE Healthcare) and Soft-
WoRx 6.1.3.
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